Similar Articles |
|
The Motley Fool October 4, 2007 Billy Fisher |
Immucor Draws First Blood The blood-testing equipment maker sees double-digit growth in both sales and earnings in Q1. |
The Motley Fool January 2, 2007 Rich Duprey |
Foolish Forecast: Bloody Good Showing for Immucor This blood-testing company's in a growth stage, but is it the right time to buy shares? |
The Motley Fool January 4, 2007 Rich Duprey |
Immucor Gets Blood Pumping Blood-testing diagnostic equipment maker beats estimates, but does so at a premium. Investors, take note. |
The Motley Fool July 13, 2011 |
Immucor Earnings Preview After beating estimates last quarter by 5 cents, Immucor has set the standard for itself this Monday, July 18. |
The Motley Fool December 16, 2003 Alyce Lomax |
Immucor Bloodied The maker of instruments used by hospitals, labs, and blood banks for blood transfusions sees its shares battered after a second-quarter earnings warning. |
The Motley Fool October 6, 2006 Brian Lawler |
No Bloodbath at Immucor The company appears right on track for double-digit revenue growth. Investors, it is worth watching to see how Immucor copes with the retirement of its CEO last month, but most likely everything should proceed as normal. |
The Motley Fool March 31, 2008 Rich Duprey |
Foolish Forecast: Immucor's Draining Acquisition In advance of earnings, analysts expect blood-tester Immucor to continue to grow sales and profits, in spite of short-term expenses. |
The Motley Fool September 24, 2007 Billy Fisher |
Getting It Done at Meridian Bioscience Impressive earnings growth and disciplined spending continue to propel this small cap up and up. Investors, take note. |
The Motley Fool March 27, 2010 Rick Aristotle Munarriz |
The Fool's Look Ahead Quarterly reports will be coming from Apollo Group, Sealy, Micron Technology, Immucor, and Research In Motion, and CarMax. The iPad will be available in stores on Saturday. |
The Motley Fool January 4, 2007 Rich Duprey |
Pressure Rising at Immucor: Fool by Numbers The blood-testing company released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
Investment Advisor November 2007 Palash R. Ghosh |
Mid-Sized, Sturdy, and Speedy One of the best performing funds in the mid-cap sector is Janus Orion Fund, which invests in a small number of companies chosen for their upside potential. |
The Motley Fool November 6, 2007 Billy Fisher |
5 Health-Care Stocks: Bargain or Bust? They have strong earnings growth and are well off their 52-week highs. Is it time to buy these health care stocks?: WellCare Health Plans... Advanced Medical Optics... NBTY... Sciele Pharma... Immucor... |
The Motley Fool April 13, 2009 Rick Aristotle Munarriz |
3 Stocks That Blew the Market Away Take a look at three stocks that beat analysts' expectations: Bed Bath & Beyond... Immucor... Apogee Enterprises... |
The Motley Fool May 10, 2006 Stephen D. Simpson |
A Test Maker Faces a Test of Its Own Beckman Coulter management seems to be tackling its challenges openly, but they're challenges nonetheless. Is the stock a buy? |